As prices for insulin skyrocket, Walmart launches ‘affordable’ brand
(NEW YORK) -- Walmart announced it is launching its own private brand of insulin, which the big box chain says will save customers with diabetes up to 75% on the lifesaving drug.
Walmart's ReliOn brand will sell private label NovoLog short-acting insulin that is manufactured... Read More.
